Published online Oct 16, 2018. doi: 10.4253/wjge.v10.i10.267
Peer-review started: May 10, 2018
First decision: June 8, 2018
Revised: July 2, 2018
Accepted: July 23, 2018
Article in press: July 23, 2018
Published online: October 16, 2018
Processing time: 159 Days and 3.6 Hours
Endoscopic ultrasound (EUS)-guided fine needle aspiration with or without biopsy (FNA/FNB) are the primary diagnostic tools for gastrointestinal submucosal tumors. EUS-guided fine needle aspiration (EUS-FNA) is considered a first line diagnostic method for the characterization of pancreatic and upper gastrointestinal lesions, since it allows for the direct visualization of the collection of specimens for cytopathologic analysis. EUS-FNA is most effective and accurate when immediate cytologic assessment is permitted by the presence of a cytopathologist on site. Unfortunately, the accuracy and thus the diagnostic yield of collected specimens suffer without this immediate analysis. Recently, a EUS-FNB needle capable of obtaining core samples (fine needle biopsy, FNB) has been developed and has shown promising results. This new tool adds a new dimension to the diagnostic and therapeutic utility of this technique. The aim of the present review is to compare the efficacy of EUS-FNA to that afforded by EUS-FNB in the characterization of pancreatic masses and of upper and lower gastrointestinal submucosal tumors.
Core tip: Endoscopic ultrasound (EUS)-guided sampling is the first diagnostic option for gastrointestinal submucosal and pancreatic lesions. In the past, fine needle aspiration (FNA) was the main method to obtain tissue for histological examination, however, it was associated with limited diagnostic accuracy. In the last decade, fine needle biopsy (FNB) needle was introduced into clinical practice, which allows for more tissue acquisition and improvement in diagnostic yield. In this updated minireview, we provide an overview on the role of EUS-FNA and FNB in certain gastrointestinal lesions. In addition, we provide a summary on the efficacy and safety profile of each procedure with reporting the recent guidelines recommendation.